References
- Ou JI, Acharya NR. Epidemiology and treatment of fungal corneal ulcers. Int Ophthalmol Clin 2007;47(3):7–16.
- Richoz O, Kling S, Hoogewoud F, HammerA, Tabibian D, Francois P, et al. Antibacterial efficacy of accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL). J Refract Surg 2014;30(12):850–854.
- Spoerl E, Huhle M, Kasper M, Seiler T. Erhohung der Festigkeit der Hornhaut durch Vernetzung. Der Ophthalmologe 1997;94(12):902–906.
- Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res 1998;66(1):97–103.
- Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003;135(5):620–627.
- O’Brart DP. Corneal collagen cross-linking: a review. J Optom 2014;7(3):113–124.
- Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 2008;27(5):590–594.
- Shetty R, Nagaraja H, Jayadev C, Shivanna Y, Kugar T. Collagen crosslinking in the management of advanced non-resolving microbial keratitis. Br J Ophthalmol 2014;98(8):1033–1035.
- Khater MM, Shehab NS, El-Badry AS. Comparison of mycotic keratitis with nonmycotic keratitis: an epidemiological study. J Ophthalmol 2014;2014: Article ID: 254302.
- Said DG, Elalfy MS, Gatzioufas Z, El-Zakzouk ES, Hassan MA, Saif MY, et al. Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology 2014;121(7):1377–1382.
- Vazirani J, Vaddavalli PK. Cross-linking for microbial keratitis. Indian J Ophthalmol 2013;61(8):441–444.
- Hafezi F, Randleman JB. PACK-CXL: defining CXL for infectious keratitis. J Refract Surg 2014;30(7):438–439.
- Sharma S. Diagnosis of infectious disease of the eye. Eye 2012;26:177–184.
- Katara RS, Patel ND, Sinha M. A clinical microbiological study of corneal ulcer patients at western Gujarat, India. Acta Medica Iranica 2013;51(6):399–403.
- Kalkan Akçay E, Açıkgöz ZC, Can ME, Çelikbilek N, Can GD, Çağıl N. Scedosporium apiospermum’a bağlı fungal keratit: ülkemizden ilk olgu. Mikrobiyol Bull 2013;47(4):727–733.
- Kalkancı A, Özdek Ş. Ocular fungal infections. Curr Eye Res 2011;36(3):179–189.
- Shobana CS, Mythili A, Homa M, Galgoczy L, Priya R, Babu Singh YR, et al. In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs. J Mycol Med 2015;25:44–49.
- Martins SAR, Combs JC, Noguera G, Camacho W, Wittman P, Walther R, et al. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophtalmol Vis Sci 2008;49(8):3402–3408.
- Sun B, Li ZW, Yu HQ, Tao XC, Zhang Y, Mu GY. Evaluation of the in vitro antimicrobial properties of ultraviolet A/riboflavin mediated crosslinking on Candida albicans and Fusarium solani. Int J Ophthalmol 2014;7(2):205–210.
- Navruzlu S, Özel U, Kıvrak İ, Kıvrak Ş, Yuksel E, Deniz G, et al. Can riboflavin penetrate stroma without disrupting integrity of corneal epithelium with iontophoresis? Ultra-Performance Liquid Tandem Mass Spectrometry in Rabbits. Cornea 2015;34(8):932–936.
- Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin cross-linking of the cornea. Cornea 2007;26(4):385–389.
- CEN (European Committee for Standardization). Chemical disinfectants—quantitative suspension test for evaluation of fungicidal activity for chemical disinfection products (phase 2/ step 1) (EN 1650).
- Tabibian D, Richoz O, Riat A, Schrenzel J, Hafezi F. Accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking as a first-line and sole treatment in early fungal keratitis. J Refract Surg 2014;30(12):855–857.
- Famose F. Evaluation of accelerated collagen cross-linking for the treatment of melting keratitis in eight dogs. Vet Ophthalmol 2014;17(5):358–367.
- Famose F. Evaluation of accelerated collagen cross-linking for the treatment of melting keratitis in ten cats. Vet Ophthalmol 2015;18(2):95–104.
- Price MO, Tenkman LR, Schrier A, Fairchild KM, Trokel SL, Price Jr FW. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refract Surg 2012;28(10):706–713.
- Anwar HM, El-Danasoury AM, Hashem AN. Corneal collagen crosslinking in the treatment of infectious keratitis. Clin Ophthalmol 2011;5:1277–1280.
- Li Z, Jhanji V, Tao X, Yu H, Chen W, Mu G. Riboflavin/ultravoilet light-mediated crosslinking for fungal keratitis. Br J Ophthalmol 2013;97(5):669–671.
- Sorkhabi R, Sedgipoor M, Mahdavifard A. Collagen cross-linking for resistant corneal ulcer. Int Ophthalmol 2013;33(1):61–66.
- Vajpayee RB, Shafi SN, Maharana PK, Sharma N, Jhanji V. Evaluation of corneal collagen cross-linking as an additional therapy in mycotic keratitis. Clin Exp Ophthalmol 2015;43(2):103–107.
- Alio JL, Abbouda A, Valle DD, Del Castillo JM, Fernandez JA. Corneal cross linking and infectious keratitis: a systematic review with a meta-analysis of reported cases. J Ophthalmic Inflamm Infect 2013;3(1):47.
- Kashiwabuchi RT, Carvalho FR, Khan YA, Hirai F, Campos MS, McDonnell PJ. Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration. Graefes Arch Clin Exp Ophthalmol 2013;251(2):521–527.
- Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, et al. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectiouskeratitis. Invest Ophthalmol Vis Sci 2008;49(8):3402–3408.